Meeting Topics
1. Non-coding-RNA activity; diagnostic and therapeutic implications.
2. Biomolecular pathogenesis of cardiovascular, hepatic and metabolic disorders.
3. Oxidative stress; cellular responses and decompensation.
4. Stem cell-based therapeutic strategies; difficulties in clinical applications.
5. Mitochondriopathies; pathophysiology and diagnostic measures.
6. Nanoparticles as therapeutic means for genetic and/or acquired diseases.